News|Articles|August 9, 2016

PharmaTech Recalls Product Due to Contamination Risk

The company is voluntarily recalling liquid products due to possible Burkholderia cepacia contamination.

PharmaTech, LLC (Davie, FL) announced on August 8, 2016 that the company was voluntarily recalling all of its liquid products manufactured from Oct. 20, 2015–July 15, 2016. The recall is due to the potential risk for Burkholderia cepacia (B. cepacia) contamination in the recalled products.

Patients with compromised immune systems and patients with chronic lung conditions could be at risk of infection if they use products contaminated with B. cepacia, according to the company. The company, however, states in a press release that it has not received any complaints of contamination associated with the recalled lots. A list of recalled lots can be found here. 

PharmaTech is notifying customers and distributors of the recall and is stating that consumers, pharmacies, and healthcare facilities should stop using the products immediately. Adverse events can be reported to FDA at www.fda.gov/medwatch/report.htm.

Source: FDA

Editor's Note: Pharmaceutical Technology magazine is not affiliated with the recall. All inquiries should be directed to PharmaTech, LLC. 


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.